Form 4: Pediatrix Director Kurt Newman Receives Equity Grant

Director Kurt Douglas Newman acquired 7,196 shares of Pediatrix Medical Group, Inc. common stock via an annual equity award.

Summary

• Director Kurt Douglas Newman was granted 7,196 restricted shares of Pediatrix Medical Group, Inc. (MD) common stock.
• The transaction occurred on May 7, 2026, at a price of $0 per share as part of an incentive compensation plan.
• Following this transaction, the director's total beneficial ownership increased to 16,933 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through increased equity ownership.
• Standard annual equity grant indicates routine compensation structure.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The shares are subject to a one-year vesting period, becoming fully vested on May 7, 2027.

Industry Context

StockSavvy.ai notes that routine equity grants to board members are standard corporate governance practices designed to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• The grant follows standard industry practices for non-employee director compensation in the healthcare services sector.
• The use of restricted stock units (RSUs) with a one-year vesting schedule is consistent with peer companies like HCA Healthcare or Tenet Healthcare.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation event.

Next Steps

• Vesting of the 7,196 restricted shares on May 7, 2027.

Key Dates

Keywords

Pediatrix Medical Group, MD, Form 4, Insider Trading, Equity Compensation, Director Ownership